Acitretin
Back to searchMolecule Structure
Scientific Name
Acitretin
Description of the Drug
Acitretin is an oral retinoid used in the treatment of severe psoriasis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00459
http://www.drugbank.ca/drugs/DB00459
Brand Name(s)
Acitretin, Neotigason, Soriatane
Company Owner(s)
Stiefel Laboratories Inc, Sigmapharm Laboratories Llc, Mylan Pharmaceuticals Inc, Barr Laboratories Inc, Teva Pharmaceuticals Usa, Impax Laboratories Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Retinoid receptor | PROTEIN FAMILY | AGONIST | CHEMBL2363071 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3759 | ||
| Human Metabolome Database | HMDB0014602 | ||
| DrugBank | DB00459 | ||
| PubChem: Thomson Pharma | 14899611 | ||
| PubChem | 5284513 | ||
| LINCS | LSM-43217 | ||
| Nikkaji | J261.795A | J23.289K | |
| BindingDB | 50088429 | ||
| EPA CompTox Dashboard | DTXSID6022553 | ||
| DrugCentral | 78 | ||
| Brenda | 31766 | 145043 | 145956 |
| ChemicalBook | CB7184686 | ||
| Guide to Pharmacology | 7598 | ||
| rxnorm | ACITRETIN | SORIATANE | |
| PubChem: Drugs of the Future | 12013101 | ||
| ChEBI | 50173 | ||
| ZINC | ZINC000003798734 |
